Radiation protection with SOD mimetics

SOD 模拟物的辐射防护

基本信息

  • 批准号:
    7310442
  • 负责人:
  • 金额:
    $ 22.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

The overall goal of this project is to develop a new strategy to protect, ameliorate and treat radiation (RT)-induced normal tissue injury by using a novel synthetic manganese(Mn)-porphyrins as potent scavengers of reactive oxygen species (ROS) and reactive nitrogen species (RNS). The strategy is based on our current mechanistic studies implicating chronic oxidative stress as an important contributing factor in the development of RT-induced normal tissue injury. We hypothesize that exposure to ionizing radiation results in chronic oxidative stress which is associated with continuous production of ROS/RNS and expression/activation of damaging cytokines involved in development of RT-induced normal tissue injury. Several lines of evidence from our group support this hypothesis. Using electron spin resonance (ESR) and spin trapping we have demonstrated the presence of ROS in rat lungs 13 weeks after irradiation. In a transgenic mouse model we have shown that overexpression of extracellular superoxide dismutase (EC-SOD), an important scavenger of ROS, ameliorates RT-induced lung injury. In addition, our studies show that Mn(III) tetrakis (N-ethylpyridinium-2-yl) porphyrin (MnTE-2-PyP5+) compound can be used to target ROS and reduce RT-induced lung damage if given prior to radiation exposure. This proposal is designed to test already established and further develop/optimize new catalytic Mn-porphyrin compounds, to document their ability to prevent/ameliorate or treat RT-induced normal tissue injury after exposure to photons or mixed neutron/photon type of ionizing radiation. With the growing threats from radiation exposure after terrorist attack, the development of effective radioprotective compounds as proposed in this project will be an important contribution for establishment of effective medical countermeasures against radiation.
该项目的总体目标是开发一种新的策略来保护、改善和治疗辐射(RT)所致的正常组织损伤,方法是使用一种新型的合成锰(Mn)-卟啉作为活性氧(ROS)和活性氮(RNS)的有效清除剂。这一策略是基于我们目前的机制研究,即慢性氧化应激是导致癌症发生的重要因素 放射治疗引起的正常组织损伤。我们假设,电离辐射暴露导致慢性氧化应激,这与ROS/RNS的持续产生和参与RT诱导的正常组织损伤的破坏性细胞因子的表达/激活有关。我们小组的几条证据支持这一假设。利用电子自旋共振(ESR)和自旋捕获技术,我们证实了照射后13周大鼠肺内ROS的存在。在转基因小鼠模型中,我们已经证明过表达细胞外超氧化物歧化酶(EC-SOD),一种重要的ROS清除剂,可以改善RT诱导的肺损伤。此外,我们的研究表明,四(N-乙基吡啶-2-基)卟啉(MnTe-2-PyP5+)化合物可用于靶向ROS,减少放射治疗所致的肺损伤。这项建议旨在测试和进一步开发/优化新的催化锰卟啉化合物,以证明它们在暴露于光子或混合中子/光子类型的电离辐射后,能够预防/改善或治疗放射治疗引起的正常组织损伤。随着恐怖袭击后辐射暴露的威胁越来越大,有效的辐射防护的发展 本项目中提出的化合物将为建立有效的辐射医学对策做出重要贡献。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ZELJKO VUJASKOVIC其他文献

ZELJKO VUJASKOVIC的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ZELJKO VUJASKOVIC', 18)}}的其他基金

Mitigation of Radiation-Induced Pulmonary Injury with Nrf2 activator
Nrf2 激活剂减轻辐射引起的肺损伤
  • 批准号:
    8573174
  • 财政年份:
    2013
  • 资助金额:
    $ 22.69万
  • 项目类别:
Mitigation of Radiation-Induced Pulmonary Injury with Nrf2 activator
Nrf2 激活剂减轻辐射引起的肺损伤
  • 批准号:
    8830429
  • 财政年份:
    2013
  • 资助金额:
    $ 22.69万
  • 项目类别:
Mitigation of Radiation-Induced Pulmonary Injury with Nrf2 activator
Nrf2 激活剂减轻辐射引起的肺损伤
  • 批准号:
    9264491
  • 财政年份:
    2013
  • 资助金额:
    $ 22.69万
  • 项目类别:
Mitigation of Radiation-Induced Pulmonary Injury with Nrf2 activator
Nrf2 激活剂减轻辐射引起的肺损伤
  • 批准号:
    8660639
  • 财政年份:
    2013
  • 资助金额:
    $ 22.69万
  • 项目类别:
Radiation Protection with SOD Mimetics
SOD 模拟物的辐射防护
  • 批准号:
    8306950
  • 财政年份:
    2011
  • 资助金额:
    $ 22.69万
  • 项目类别:
Radiation Protection with SOD Mimetics
SOD 模拟物的辐射防护
  • 批准号:
    8013118
  • 财政年份:
    2010
  • 资助金额:
    $ 22.69万
  • 项目类别:
Antioxidant Mimetic as a Mitigator of Radiation Induced Lung Injury
抗氧化剂模拟物作为辐射引起的肺损伤的缓解剂
  • 批准号:
    7586542
  • 财政年份:
    2010
  • 资助金额:
    $ 22.69万
  • 项目类别:
MECHANISM OF RADIATION-INDUCED LUNG INJURY
辐射引起的肺损伤的机制
  • 批准号:
    7601181
  • 财政年份:
    2007
  • 资助金额:
    $ 22.69万
  • 项目类别:
SPATIAL DISTRIBUTION OF PULMONARY FUNCTION OF THE RAT LUNG
大鼠肺功能的空间分布
  • 批准号:
    7601157
  • 财政年份:
    2007
  • 资助金额:
    $ 22.69万
  • 项目类别:
SPATIAL DISTRIBUTION OF PULMONARY FUNCTION OF THE RAT LUNG
大鼠肺功能的空间分布
  • 批准号:
    7358307
  • 财政年份:
    2006
  • 资助金额:
    $ 22.69万
  • 项目类别:

相似海外基金

International cooperative study for spatial-temporal disease clustering and risk factors on emerging infectious diseases
新发传染病时空疾病聚集性及危险因素国际合作研究
  • 批准号:
    20KK0218
  • 财政年份:
    2020
  • 资助金额:
    $ 22.69万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
Molecular Pathological Analysis in Salivary Duct Carcinoma from the perspective on the Development of the Personalized Treatments: A Large Multicenter Cooperative Study.
从个性化治疗发展的角度进行唾液管癌的分子病理学分析:一项大型多中心合作研究。
  • 批准号:
    17K08705
  • 财政年份:
    2017
  • 资助金额:
    $ 22.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Alzheimer's Disease Cooperative Study
阿尔茨海默病合作研究
  • 批准号:
    9244252
  • 财政年份:
    2016
  • 资助金额:
    $ 22.69万
  • 项目类别:
Alzheimer's Disease Cooperative Study
阿尔茨海默病合作研究
  • 批准号:
    9021933
  • 财政年份:
    2015
  • 资助金额:
    $ 22.69万
  • 项目类别:
Global Cooperative Study on Quality Assurance of Career Education through Writing Development
通过写作发展保证职业教育质量的全球合作研究
  • 批准号:
    24530966
  • 财政年份:
    2012
  • 资助金额:
    $ 22.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Alzheimer's Disease Cooperative Study - Project #2
阿尔茨海默病合作研究 - 项目
  • 批准号:
    245483
  • 财政年份:
    2010
  • 资助金额:
    $ 22.69万
  • 项目类别:
    Operating Grants
Alzheimer's Disease Cooperative Study - Project #4
阿尔茨海默病合作研究 - 项目
  • 批准号:
    245485
  • 财政年份:
    2010
  • 资助金额:
    $ 22.69万
  • 项目类别:
    Operating Grants
Alzheimer's Disease Cooperative Study #5
阿尔茨海默病合作研究
  • 批准号:
    245486
  • 财政年份:
    2010
  • 资助金额:
    $ 22.69万
  • 项目类别:
    Operating Grants
Alzheimer's Disease Cooperative Study - Project #3
阿尔茨海默病合作研究 - 项目
  • 批准号:
    245484
  • 财政年份:
    2010
  • 资助金额:
    $ 22.69万
  • 项目类别:
    Operating Grants
Alzheimer's Disease Cooperative Study - Project #1
阿尔茨海默病合作研究 - 项目
  • 批准号:
    245482
  • 财政年份:
    2010
  • 资助金额:
    $ 22.69万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了